Britt‐Marie Swahn

895 total citations
24 papers, 635 citations indexed

About

Britt‐Marie Swahn is a scholar working on Physiology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Britt‐Marie Swahn has authored 24 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 10 papers in Molecular Biology and 10 papers in Computational Theory and Mathematics. Recurrent topics in Britt‐Marie Swahn's work include Alzheimer's disease research and treatments (13 papers), Computational Drug Discovery Methods (10 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Britt‐Marie Swahn is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Computational Drug Discovery Methods (10 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Britt‐Marie Swahn collaborates with scholars based in Sweden, United Kingdom and Canada. Britt‐Marie Swahn's co-authors include Fredrik Jeppsson, Jan Neelissen, Samuel Svensson, Jenny Viklund, Karin Kolmodin, Anders Juréus, Johan Sandell, Johanna Fälting, Stefan von Berg and Peter Johnström and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Journal of Bacteriology.

In The Last Decade

Britt‐Marie Swahn

24 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Britt‐Marie Swahn Sweden 13 299 243 204 151 133 24 635
Erik Wagner United States 9 370 1.2× 316 1.3× 206 1.0× 103 0.7× 160 1.2× 11 748
Thomas Luebbers Switzerland 13 295 1.0× 434 1.8× 255 1.3× 290 1.9× 170 1.3× 18 868
Tyler E. Benedum United States 7 344 1.2× 202 0.8× 63 0.3× 193 1.3× 52 0.4× 8 634
Hiroshi Shimadzu Japan 9 279 0.9× 137 0.6× 64 0.3× 77 0.5× 72 0.5× 17 443
Martin Pettersson United States 15 168 0.6× 269 1.1× 120 0.6× 339 2.2× 124 0.9× 25 736
Hartmut E. Greiner Germany 17 89 0.3× 394 1.6× 60 0.3× 234 1.5× 100 0.8× 32 839
Sharan K. Bagal United Kingdom 14 123 0.4× 582 2.4× 67 0.3× 296 2.0× 78 0.6× 20 938
Dawn A. Brooks United States 11 182 0.6× 196 0.8× 41 0.2× 342 2.3× 125 0.9× 26 651
Małgorzata Rózga Poland 12 439 1.5× 294 1.2× 87 0.4× 25 0.2× 47 0.4× 12 750
Rainer Machauer Switzerland 15 216 0.7× 311 1.3× 225 1.1× 189 1.3× 149 1.1× 20 660

Countries citing papers authored by Britt‐Marie Swahn

Since Specialization
Citations

This map shows the geographic impact of Britt‐Marie Swahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britt‐Marie Swahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britt‐Marie Swahn more than expected).

Fields of papers citing papers by Britt‐Marie Swahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britt‐Marie Swahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britt‐Marie Swahn. The network helps show where Britt‐Marie Swahn may publish in the future.

Co-authorship network of co-authors of Britt‐Marie Swahn

This figure shows the co-authorship network connecting the top 25 collaborators of Britt‐Marie Swahn. A scholar is included among the top collaborators of Britt‐Marie Swahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britt‐Marie Swahn. Britt‐Marie Swahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eklund, Göran, Jonas Malmquist, Britt‐Marie Swahn, et al.. (2013). Biotransformation of Two β-Secretase Inhibitors Including Ring Opening and Contraction of a Pyrimidine Ring. Drug Metabolism and Disposition. 41(5). 1134–1147. 4 indexed citations
2.
Eketjäll, Susanna, Juliette Janson, Fredrik Jeppsson, et al.. (2013). AZ-4217: A High Potency BACE Inhibitor Displaying Acute Central Efficacy in Different In Vivo Models and Reduced Amyloid Deposition in Tg2576 Mice. Journal of Neuroscience. 33(24). 10075–10084. 34 indexed citations
3.
Forsberg, Anton, Anders Juréus, Zsolt Cselényi, et al.. (2013). Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer’s disease patients. European Journal of Nuclear Medicine and Molecular Imaging. 40(4). 580–593. 15 indexed citations
4.
Swahn, Britt‐Marie, Johan Sandell, Margareta Bergh, et al.. (2012). Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as 18F-PET imaging agents for β-amyloid plaques. Bioorganic & Medicinal Chemistry Letters. 22(13). 4332–4337. 19 indexed citations
5.
Swahn, Britt‐Marie, Jörg Holenz, Karin Kolmodin, et al.. (2012). Aminoimidazoles as BACE-1 inhibitors: The challenge to achieve in vivo brain efficacy. Bioorganic & Medicinal Chemistry Letters. 22(5). 1854–1859. 34 indexed citations
6.
Jeppsson, Fredrik, Susanna Eketjäll, Juliette Janson, et al.. (2012). Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease. Journal of Biological Chemistry. 287(49). 41245–41257. 107 indexed citations
7.
Gravenfors, Ylva, Jenny Viklund, Sofia Karlström, et al.. (2012). New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain. Journal of Medicinal Chemistry. 55(21). 9297–9311. 56 indexed citations
8.
Svensson, Samuel, Fredrik Jeppsson, Anders Juréus, et al.. (2012). IC‐P‐045: Comparison of beta‐amyloid imaging using congo red and thioflavin T derivatives. Alzheimer s & Dementia. 8(4S_Part_1). 1 indexed citations
9.
10.
Luker, Tim, Lilian Alcaraz, Kamaldeep K. Chohan, et al.. (2011). Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules. Bioorganic & Medicinal Chemistry Letters. 21(19). 5673–5679. 49 indexed citations
11.
Juréus, Anders, Britt‐Marie Swahn, Johan Sandell, et al.. (2010). Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand. Journal of Neurochemistry. 114(3). 784–794. 109 indexed citations
12.
Andersson, Jan, Katarina Varnäs, Zsolt Cselényi, et al.. (2010). Radiosynthesis of the candidate β‐amyloid radioligand [11C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys. Synapse. 64(10). 733–741. 23 indexed citations
13.
Swahn, Britt‐Marie, David Wensbo, Johan Sandell, et al.. (2010). Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for β-amyloid plaques. Bioorganic & Medicinal Chemistry Letters. 20(6). 1976–1980. 24 indexed citations
14.
Swahn, Britt‐Marie, et al.. (2009). Liver X receptor agonists with selectivity for LXRβ; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides. Bioorganic & Medicinal Chemistry Letters. 19(7). 2009–2012. 7 indexed citations
15.
Sundgren‐Andersson, Anna K., Samuel Svensson, Britt‐Marie Swahn, et al.. (2009). P2‐023: AZD4694: Fluorinated Positron Emission Tomography (PET) radioligand for detection of β‐amyloid deposits. Alzheimer s & Dementia. 5(4S_Part_9). 4 indexed citations
16.
Swahn, Britt‐Marie, et al.. (2005). Design and synthesis of 2′-anilino-4,4′-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3. Bioorganic & Medicinal Chemistry Letters. 16(5). 1397–1401. 43 indexed citations
17.
Swahn, Britt‐Marie, Fernando F. Huerta, Jonas Malmström, et al.. (2005). Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3. Bioorganic & Medicinal Chemistry Letters. 15(22). 5095–5099. 55 indexed citations
18.
Swahn, Britt‐Marie, et al.. (1997). Two non-racemic preparations of a piperidine-based NMDA antagonist with analgesic activity. Bioorganic & Medicinal Chemistry. 5(7). 1293–1299. 2 indexed citations
19.
Swahn, Britt‐Marie, Фредрик Андерссон, Benjamin Pelcman, Johan Söderberg, & Alf Claesson. (1997). Synthesis of 14C-labelled (R)-α-amino-6,7-dimethyl-3-(phosphonomethyl)-2-quinolinepropanoic acid. Journal of Labelled Compounds and Radiopharmaceuticals. 39(3). 259–266. 8 indexed citations
20.
Swahn, Britt‐Marie, et al.. (1996). New heteroaryl-spaced phosphono α-amino acids are competitive NMDA antagonists with analgesic activity. Bioorganic & Medicinal Chemistry Letters. 6(14). 1635–1640. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik Wagner Breakdown of academic impact, for papers by Thomas Luebbers Breakdown of academic impact, for papers by Tyler E. Benedum Breakdown of academic impact, for papers by Hiroshi Shimadzu Breakdown of academic impact, for papers by Martin Pettersson Breakdown of academic impact, for papers by Hartmut E. Greiner Breakdown of academic impact, for papers by Sharan K. Bagal Breakdown of academic impact, for papers by Dawn A. Brooks Breakdown of academic impact, for papers by Małgorzata Rózga Breakdown of academic impact, for papers by Rainer Machauer
Rankless by CCL
2026